Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Coengineering specificity, safety, and function into T cells for cancer immunotherapy
Greta Maria Paola Giordano Attianese, Sarah Ash, Melita Irving
Immunological Reviews (2023) Vol. 320, Iss. 1, pp. 166-198
Open Access | Times Cited: 16

Showing 16 citing articles:

Targeting the activated microenvironment with endosialin (CD248)-directed CAR-T cells ablates perivascular cells to impair tumor growth and metastasis
Sarah Ash, Rebecca Orha, Holly Mole, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 2, pp. e008608-e008608
Open Access | Times Cited: 11
Recent Updates on Chimeric Antigen Receptor T-Cell Approaches in Cancer Immunotherapy
Maryam Sahlolbei, Amirhossein Ahmadieh-Yazdi, Mohadeseh Rostamipoor, et al.
IntechOpen eBooks (2024)
Open Access | Times Cited: 5
DNA-Dependent Protein Kinase Inhibitors PI-103 and Samotolisib Augment CRISPR/Cas9 Knock-in Efficiency in Human T Cells
Emina Džafo, Morteza Hafezi, Greta Maria Paola Giordano Attianese, et al.
Cytotherapy (2025)
Closed Access
Recent developments on checkpoint inhibitors, CAR T cells, and beyond for T cell-based immunotherapeutic strategies against cancer
Shaukat Ali, Mahnoor Arshad, Muhammad Summer, et al.
Journal of Oncology Pharmacy Practice (2025)
Closed Access
ReCARving the future: bridging CAR T-cell therapy gaps with synthetic biology, engineering, and economic insights
Alaa M. Ali, John F. DiPersio
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
In Situ Cancer Vaccines: Redefining Immune Activation in the Tumor Microenvironment
Prabhanjan S. Giram, Kazi Md Mahabubur Rahman, Osama Aqel, et al.
ACS Biomaterials Science & Engineering (2025)
Closed Access
Combining SiRPα decoy–coengineered T cells and antibodies augments macrophage-mediated phagocytosis of tumor cells
Evangelos Stefanidis, Aikaterini Semilietof, J. Olmedo Pujol, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 11
Open Access | Times Cited: 3
TALEN-edited Allogeneic Inducible Dual CAR T-cells Enable Effective Targeting of Solid Tumors while Mitigating Off-Tumor Toxicity
Sonal Dharani, Hana Cho, Jorge Postigo, et al.
Molecular Therapy (2024) Vol. 32, Iss. 11, pp. 3915-3931
Open Access | Times Cited: 3
Distinct host preconditioning regimens differentially impact the antitumor potency of adoptively transferred Th17 cells
Megen C Wittling, Hannah M. Knochelmann, Megan M Wyatt, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 6, pp. e008715-e008715
Open Access | Times Cited: 2
Metabolic predictors of response to immune checkpoint blockade therapy
Ofir Shorer, Keren Yizhak
iScience (2023) Vol. 26, Iss. 11, pp. 108188-108188
Open Access | Times Cited: 4
Dual ON/OFF-switch chimeric antigen receptor controlled by two clinically approved drugs
Greta Maria Paola Giordano Attianese, Sailan Shui, Elisabetta Cribioli, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 44
Open Access | Times Cited: 1
Drug-controlled CAR-T cells through the regulation of cell-cell interactions
Leo Scheller, Greta Maria Paola Giordano Attianese, Rocío Castellanos-Rueda, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Pyroptosis in Lung Cancer: The Emerging Role of Non-Coding RNAs
Lakshmi Thangavelu, Ahsas Goyal, Muhammad Afzal, et al.
Pathology - Research and Practice (2024) Vol. 263, pp. 155619-155619
Closed Access
DNA-Dependent Protein Kinase Inhibitors PI-103 and Samotolisib Augment CRISPR/Cas9 Knockin Efficiency in Human T Cells
Emina Džafo, Morteza Hafezi, Greta Maria Paola Giordano Attianese, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Preclinical model for evaluating human TCRs against chimeric syngeneic tumors
Aikaterini Semilietof, Evangelos Stefanidis, Elise Gray-Gaillard, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 12, pp. e009504-e009504
Open Access
Golden age of immunoengineering
Wilson W. Wong, Wendell A. Lim
Immunological Reviews (2023) Vol. 320, Iss. 1, pp. 4-9
Open Access
Distinct host preconditioning regimens differentially impact the antitumor potency of adoptively transferred Th17 cells.
Megen C Wittling, Hannah M. Knochelmann, Megan M. Wyatt, et al.
(2023)
Open Access
Page 1

Scroll to top